Entwodiksyonak aplikasyonnan Nimewo CAS 956104-40-8|Apalutamid
Yon antagonist ki pisan nan reseptè androjèn ak IC50valè 16 nM. Mare reseptè androjèn, kidonk anpeche translokasyon nikleyè, ADN obligatwa ak aktivasyon transcriptional. Gen aplikasyon terapetik nan kansè pwostat ki pa metastatik, ki reziste kastrasyon.
Sinonim:
ARN-509;
4-(7-(6-cyano-5-(trifluoroMethyl)piridin-3-il)-8-oxo-6-thioxo{{7} },7-diazaspirooktan-5-yl)-2-fluoro-N-MethylbenzaMide;
AR509;benzamid,4-[7-[6-syan-5-(trifluorometil)-3-piridinil]-8-oxo-6-tioks{{ {8}},7-diazaspiro[3.4]oct-5-yl]-2-fluoro-N-methyl-;
4-[7-[6-Syano-5-(trifluorometil)piridin-3-il]-8-oxo-6-tioxo{{7} },7-diazaspiro[3.4]oktan-5-yl]-2-fluoro-N-methylbenzamideARN-509;
AR509100G;4-[7-[6-Syano-5-(trifluorometil)piridin-3-il]-8-oxo-6-tioxo{{ 8}},7-diazaspiro[3.4]oktan-5-yl]-2-fluoro-N-methylbenzamid;
Spesifikasyon nan Nimewo CAS 956104-40-8|Apalutamid
|
ATIK |
SPESIFIKASYON |
|
CAS |
956104-40-8 |
|
MF |
C21H15F4N5O2S |
|
mw |
477.43 |
|
Dansite |
1.59±0.1 g/cm3 (Prevwa) |
|
koyefisyan asidite (pKa) |
13.83±0.46(Prevwa) |
Pake ak transpònan Entwodiksyon ak aplikasyon nanNimewo CAS 956104-40-8|Apalutamid
Pake: 0.1g,1g,5g,25g,100g,500g,1kg
Transpò: pa courrier / pa lè / pa lanmè

Atik ki gen rapò ak nimewo CAS 956104-40-8|Apalutamid
[HTML] Apalutamide ak siviv jeneral nan kansè pwostat
MR Smith, F Saad, S Chowdhury, S Oudard... - Ewopeyen uroloji, 2021 - Elsevier
… gwoup apalutamid pase nan gwoup plasebo a (apalutamid, 32.9 mwa; plasebo, 11.5 mwa).
Dire medyàn tretman ak apalutamid ... te menm jan an ant apalutamid la ak plasebo ...
Baj popilè: ka non.956104-40-8|apalutamide, Lachin cas non.956104-40-8|Apalutamide manifakti yo, faktori









![CAS:1448189-80-7|(2S,4R)-1-[(2S)-2-amino-3,3-dimethylbutanoyl]-4-hydroxy-N- [[4-({4-metil-1,3-tiazol-5-il)fenil]methyl]pirrolidin-2-karboxamid Hydrochloride](/uploads/202340266/small/cas-1448189-80-7-2s-4r-1-2s-2-amino-3-3157a042f-8fdf-4f32-b6f7-e81d9ccfe648.png?size=195x0)


